[1. Ruxandra Calin, Adriana Hristea, Radu Tanasescu (2012). Central Nervous System Involvement in Lyme Disease - Making the Diagnosis and Choosing the Correct Treatment, Miscellanea on Encephalopathies, Radu Tanasescu (Ed.), ISBN: 978-953-51-0499-5, InTech, DOI: 10.5772/37669.10.5772/37669]Search in Google Scholar
[2. Hildenbrand P, Craven DE, Jones R, Nemeskal P. Lyme neuroborreliosis: manifestations of a rapidly emerging zoonosis. AJNR Am J Neuroradiol. 2009;30(6):1079-87. doi: 10.3174/ajnr.A1579.10.3174/ajnr.A1579]Search in Google Scholar
[3. Blanc F, Gebly. Neurologic and psychiatric manifestations of Lyme disease. Medecine et Maladies Infectieuses 2007;37(7-8):435-445.10.1016/j.medmal.2006.01.025]Search in Google Scholar
[4. Zhang Y, Lafontant G, Bonner FJ Jr. Lyme neuroborreliosis mimics stroke: a case report. Arch Phys Med Rehabil. 2000;81(4):519-521.10.1053/mr.2000.4431]Search in Google Scholar
[5. Garcia-Monco JC, Benach JI. Lyme neuroborreliosis. Ann Neurol. 1995;37:691-702.10.1002/ana.410370602]Search in Google Scholar
[6. Reik L, Steere AC, Bartenhagen NH, Shope RE, Malawista SE. Neurologic abnormalities of Lyme disease. Medicine (Baltimore). 1979;58(4):281-294.10.1097/00005792-197907000-00001]Search in Google Scholar
[7. Steere AC. Lyme disease. N Engl J Med 2001;345(2):115-125.10.1056/NEJM200107123450207]Search in Google Scholar
[8. Subedi S, Dickeson DJ, Branley JM. First report of Lyme neuroborreliosis in a returned Australian traveller. Med J Aust. 2015;203(1):39-40.10.5694/mja14.01592]Search in Google Scholar
[9. Stanek G, Strle F. Lyme borreliosis. Lancet. 2003;362(9396):1639-1647.10.1016/S0140-6736(03)14798-8]Search in Google Scholar
[10. Rahn DW, Felz MW. Lyme disease update. Current approach to early, disseminated, and late disease. Postgrad Med. 1998;103(5):51-4,57-9,63-4passim.10.3810/pgm.1998.05.4829590986]Search in Google Scholar
[11. Dessau RB, Espenhain L, Mølbak K, Krause TG, Voldstedlund M. Improving national surveillance of Lyme neuroborreliosis in Denmark through electronic reporting of specific antibody index testing from 2010 to 2012. Euro Surveill. 2015;20(28).pii:21184.10.2807/1560-7917.ES2015.20.28.21184]Search in Google Scholar
[12. Tobias A Rupprecht, Volker Fingerle. Neuroborreliosis: pathogenesis, symptoms, diagnosis and treatment. Future Neurology. 2011;6(2):273-289. DOI: 10.2217/fnl.10.89.10.2217/fnl.10.89]Search in Google Scholar
[13. Jassam YN, Thaler DE. Lyme meningo-radiculitis responsive to oral doxycycline therapy in the USA. Oxf Med Case Reports. 2014;2014(9):162-163. doi: 10.1093/omcr/omu061. eCollection 2014.10.1093/omcr/omu061]Search in Google Scholar
[14. Halperin JJ. Nervous system lyme disease: is there a controversy? Semin Neurol. 2011;31(3):317-324. doi: http://dx.doi.org/10.1055/s-0031-1287652.]Search in Google Scholar
[15. Halperin JJ. Chronic Lyme disease: misconceptions and challenges for patient management. Infect Drug Resist. 2015;8:119-28. doi: 10.2147/IDR.S66739. eCollection 2015.10.2147/IDR.S66739]Search in Google Scholar
[16. Garin C, Bujadoux A. Paralysie par les tiques. (tick paralysis). J Med Lyon. 1922;71:765-767.]Search in Google Scholar
[17. Mygland Å, Ljøstad U, Fingerle V, et al. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010;17:8-16,e1-4.]Search in Google Scholar
[18. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of lyme borreliosis. Clin Microbiol Rev. 2005;18(3):484-509.10.1128/CMR.18.3.484-509.2005]Search in Google Scholar
[19. Hengge UR, Tannapfel A, Tyring SK, Erbel R, Arendt G, Ruzicka T. Lyme borreliosis. Lancet Infect Dis. 2003;3(8):489-500.10.1016/S1473-3099(03)00722-9]Search in Google Scholar
[20. Mygland A, Ljøstad U, Fingerle V, et al. European Federation of Neurological Societies. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010;17(1):8-16,e1-4. doi: 10.1111/j.1468-1331.2009.02862.x.10.1111/j.1468-1331.2009.02862.x]Search in Google Scholar
[21. Ljøstad U, Skogvoll E, Eikeland R, et al. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol. 2008;7(8):690-695. doi: 10.1016/S1474-4422(08)70119-4.10.1016/S1474-4422(08)70119-4]Search in Google Scholar
[22. Eikeland R, Ljøstad U, Mygland A, Herlofson K, Løhaugen GC. European neuroborreliosis: neuropsychological findings 30 months post-treatment. Eur J Neurol. 2012;19(3):480-487. doi: 10.1111/j.1468-1331.2011.03563.x.10.1111/j.1468-1331.2011.03563.x21999112]Search in Google Scholar
[23. Ljøstad U, Mygland A. Remaining complaints 1 year after treatment for acute Lyme neuroborreliosis; frequency, pattern and risk factors. Eur J Neurol. 2010;17(1):118-123. doi: 10.1111/j.1468-1331.2009.02756.x.10.1111/j.1468-1331.2009.02756.x19645771]Search in Google Scholar